biospecimen_aliquot__bcr_aliquot_barcode	tcga-ao-a129-01a-21d-a10m-09
biospecimen_aliquot__bcr_aliquot_uuid	cdf43c25-3ba7-4073-a92d-4a97f651f4a8
biospecimen_aliquot__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_aliquot__bcr_sample_barcode	tcga-ao-a129-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100474428
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2010-12-14
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	3
biospecimen_aliquot__plate_id	a10m
biospecimen_aliquot__plate_row	g
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	1.97
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ao-a129-01a-21d
biospecimen_analyte__bcr_analyte_uuid	1f0ed4e2-e1c8-4472-8c3b-efe696c02c29
biospecimen_analyte__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_analyte__bcr_sample_barcode	tcga-ao-a129-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ao-a129
biospecimen_diagnostic_slides__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ao-a129-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	bf485416-bf57-4f39-866b-4b1e201876fa
biospecimen_normal_control__bcr_patient_barcode	tcga-ao-a129
biospecimen_normal_control__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_normal_control__ncedna_dna_conc	0.14
biospecimen_normal_control__ncedna_dna_qm	nanodrop
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	145
biospecimen_portion__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_portion__bcr_portion_barcode	tcga-ao-a129-01a-21
biospecimen_portion__bcr_portion_uuid	f79874dc-2799-4983-aa28-f2d7f0c6e9e4
biospecimen_portion__bcr_sample_barcode	tcga-ao-a129-01a
biospecimen_portion__date_of_creation	2010-11-24
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ao-a129-01a-21d
biospecimen_protocol__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_protocol__bcr_sample_barcode	tcga-ao-a129-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_sample__bcr_sample_barcode	tcga-ao-a129-01a
biospecimen_sample__bcr_sample_uuid	fe3921db-1691-432f-b7fa-703ae8d7bfd2
biospecimen_sample__days_to_collection	2915
biospecimen_sample__initial_weight	320
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ao-a129.dd973a0e-3cc3-4ed7-be2c-7e5e3c55032b.pdf
biospecimen_sample__pathology_report_uuid	dd973a0e-3cc3-4ed7-be2c-7e5e3c55032b
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ao-a129-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	480c68cf-c569-476a-86eb-cd14d5ba6b54
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13e
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ao-a129-01a-11-a13e-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
biospecimen_slide__bcr_sample_barcode	tcga-ao-a129-01a
biospecimen_slide__bcr_slide_barcode	tcga-ao-a129-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	427ec681-3c44-4d87-bfe5-525df3ade7f2
biospecimen_slide__image_file_name	tcga-ao-a129-01a-02-tsb.427ec681-3c44-4d87-bfe5-525df3ade7f2.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	15
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	85
biospecimen_slide__percent_tumor_nuclei	75
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ao-a129
biospecimen_tumor_sample__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
clinical_drug__bcr_drug_barcode	tcga-ao-a129-d5950
clinical_drug__bcr_drug_uuid	2c562434-088f-444b-82ca-9ad77b8fdaa2
clinical_drug__bcr_patient_barcode	tcga-ao-a129
clinical_drug__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
clinical_drug__form_completion_date	2011-1-10
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	paclitaxel
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/m2
clinical_drug__pharmaceutical_tx_ended_days_to	162
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	67
clinical_drug__prescribed_dose	175
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-ao-a129-f19415
clinical_follow_up__bcr_followup_uuid	c40939d7-1f54-4652-beef-94586a5f9051
clinical_follow_up__bcr_patient_barcode	tcga-ao-a129
clinical_follow_up__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-12-12
clinical_follow_up__last_contact_days_to	3286
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	29
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	5th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left lower outer quadrant|left
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-ao-a129
clinical_patient__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
clinical_patient__birth_days_to	-10898
clinical_patient__cent17_copy_number	49
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	negative
clinical_patient__er_status_ihc_Percent_Positive	<10%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-12-8
clinical_patient__gender	female
clinical_patient__her2_and_cent17_cells_count	31
clinical_patient__her2_cent17_ratio	1.0
clinical_patient__her2_copy_number	52
clinical_patient__her2_fish_method	>=2.0 positive
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_ihc_score	0
clinical_patient__her2_positivity_method_text	3+ positive
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2002
clinical_patient__last_contact_days_to	2923
clinical_patient__lymph_nodes_examined_count	21
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a129
clinical_patient__pr_status_by_ihc	negative
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ao
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-ao-a129
clinical_radiation__bcr_patient_uuid	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba
clinical_radiation__bcr_radiation_barcode	tcga-ao-a129-r5883
clinical_radiation__bcr_radiation_uuid	0417042c-5493-4b8d-b969-7077215b602d
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-12-8
clinical_radiation__radiation_therapy_ended_days_to	246
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	regional site
clinical_radiation__radiation_therapy_started_days_to	216
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AO-A129-01A-21D-A10M-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AO-A129-01A-21D-A10M-09.bed.meta
manually_curated__id	tcga-ao-a129-01a-21d-a10m-09
manually_curated__md5sum	250760a6373f560136f933eb26bbd83b
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	cdf43c25-3ba7-4073-a92d-4a97f651f4a8
manually_curated__tumor_tag	brca
